Azenta (AZTA)
(Delayed Data from NSDQ)
$52.10 USD
-0.36 (-0.69%)
Updated May 1, 2024 04:00 PM ET
After-Market: $52.12 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
AZTA 52.10 -0.36(-0.69%)
Will AZTA be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AZTA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AZTA
Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates
Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?
AZTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Health, Inc. (HIMS) Moves 8.3% Higher: Will This Strength Last?
3 Stocks to Watch After Impressive Earnings Beats
Azenta (AZTA) Beats Q3 Earnings and Revenue Estimates
Other News for AZTA
Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
ROBO ETF: A Diversified Investment Into The Future
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Azenta (AZTA) Shares Cross Below 200 DMA
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta